世界の黒色腫市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Melanoma Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3681 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、黒色腫のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、免疫療法、標的療法、放射線療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・黒色腫の市場動向 ・企業の競争状況、市場シェア ・黒色腫の種類別市場規模（化学療法、免疫療法、標的療法、放射線療法） ・黒色腫の用途別市場規模（病院、クリニック、その他） ・黒色腫の北米市場規模2016-2027（アメリカ、カナダ） ・黒色腫のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・黒色腫のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・黒色腫の中南米市場規模2016-2027（メキシコ、ブラジル） ・黒色腫の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、Eristol-Mayers Squibb、Eisai、Roche、Genetech、Janssen Biotech、Pfizer、Novartis、Vical、Ziopharm） ・結論

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Sometimes they develop from a mole with changes such as an increase in size, irregular edges, change in color, itchiness, or skin breakdown.
Confirmation of the clinical diagnosis is done with a skin biopsy. It is usually followed up with a wider excision of the scar or tumor. Depending on the stage, a sentinel lymph node biopsy may be performed. Treatment of advanced malignant melanoma is performed from a multidisciplinary approach.

Market Analysis and Insights: Global Melanoma Market
The global Melanoma market size is projected to reach US$ 8775.1 million by 2026, from US$ 5536.4 million in 2019, at a CAGR of 6.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Melanoma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Melanoma market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Melanoma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Melanoma market.

Global Melanoma Scope and Market Size
Melanoma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Melanoma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Immunotherapy
Targeted Therapy
Radiation Therapy

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen
Eristol-Mayers Squibb
Eisai
Roche
Genetech
Janssen Biotech
Pfizer
Novartis
Vical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melanoma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.2.5 Radiation Therapy
1.3 Market by Application
1.3.1 Global Melanoma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Melanoma Market Perspective (2016-2027)
2.2 Melanoma Growth Trends by Regions
2.2.1 Melanoma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Melanoma Historic Market Share by Regions (2016-2021)
2.2.3 Melanoma Forecasted Market Size by Regions (2022-2027)
2.3 Melanoma Industry Dynamic
2.3.1 Melanoma Market Trends
2.3.2 Melanoma Market Drivers
2.3.3 Melanoma Market Challenges
2.3.4 Melanoma Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Melanoma Players by Revenue
3.1.1 Global Top Melanoma Players by Revenue (2016-2021)
3.1.2 Global Melanoma Revenue Market Share by Players (2016-2021)
3.2 Global Melanoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Melanoma Revenue
3.4 Global Melanoma Market Concentration Ratio
3.4.1 Global Melanoma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melanoma Revenue in 2020
3.5 Melanoma Key Players Head office and Area Served
3.6 Key Players Melanoma Product Solution and Service
3.7 Date of Enter into Melanoma Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Melanoma Breakdown Data by Type
4.1 Global Melanoma Historic Market Size by Type (2016-2021)
4.2 Global Melanoma Forecasted Market Size by Type (2022-2027)

5 Melanoma Breakdown Data by Application
5.1 Global Melanoma Historic Market Size by Application (2016-2021)
5.2 Global Melanoma Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Melanoma Market Size (2016-2027)
6.2 North America Melanoma Market Size by Type
6.2.1 North America Melanoma Market Size by Type (2016-2021)
6.2.2 North America Melanoma Market Size by Type (2022-2027)
6.2.3 North America Melanoma Market Size by Type (2016-2027)
6.3 North America Melanoma Market Size by Application
6.3.1 North America Melanoma Market Size by Application (2016-2021)
6.3.2 North America Melanoma Market Size by Application (2022-2027)
6.3.3 North America Melanoma Market Size by Application (2016-2027)
6.4 North America Melanoma Market Size by Country
6.4.1 North America Melanoma Market Size by Country (2016-2021)
6.4.2 North America Melanoma Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Melanoma Market Size (2016-2027)
7.2 Europe Melanoma Market Size by Type
7.2.1 Europe Melanoma Market Size by Type (2016-2021)
7.2.2 Europe Melanoma Market Size by Type (2022-2027)
7.2.3 Europe Melanoma Market Size by Type (2016-2027)
7.3 Europe Melanoma Market Size by Application
7.3.1 Europe Melanoma Market Size by Application (2016-2021)
7.3.2 Europe Melanoma Market Size by Application (2022-2027)
7.3.3 Europe Melanoma Market Size by Application (2016-2027)
7.4 Europe Melanoma Market Size by Country
7.4.1 Europe Melanoma Market Size by Country (2016-2021)
7.4.2 Europe Melanoma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Melanoma Market Size (2016-2027)
8.2 Asia-Pacific Melanoma Market Size by Type
8.2.1 Asia-Pacific Melanoma Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Melanoma Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Melanoma Market Size by Type (2016-2027)
8.3 Asia-Pacific Melanoma Market Size by Application
8.3.1 Asia-Pacific Melanoma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Melanoma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Melanoma Market Size by Application (2016-2027)
8.4 Asia-Pacific Melanoma Market Size by Region
8.4.1 Asia-Pacific Melanoma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Melanoma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Melanoma Market Size (2016-2027)
9.2 Latin America Melanoma Market Size by Type
9.2.1 Latin America Melanoma Market Size by Type (2016-2021)
9.2.2 Latin America Melanoma Market Size by Type (2022-2027)
9.2.3 Latin America Melanoma Market Size by Type (2016-2027)
9.3 Latin America Melanoma Market Size by Application
9.3.1 Latin America Melanoma Market Size by Application (2016-2021)
9.3.2 Latin America Melanoma Market Size by Application (2022-2027)
9.3.3 Latin America Melanoma Market Size by Application (2016-2027)
9.4 Latin America Melanoma Market Size by Country
9.4.1 Latin America Melanoma Market Size by Country (2016-2021)
9.4.2 Latin America Melanoma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Melanoma Market Size (2016-2027)
10.2 Middle East & Africa Melanoma Market Size by Type
10.2.1 Middle East & Africa Melanoma Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Melanoma Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Melanoma Market Size by Type (2016-2027)
10.3 Middle East & Africa Melanoma Market Size by Application
10.3.1 Middle East & Africa Melanoma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Melanoma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Melanoma Market Size by Application (2016-2027)
10.4 Middle East & Africa Melanoma Market Size by Country
10.4.1 Middle East & Africa Melanoma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Melanoma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Melanoma Introduction
11.1.4 Amgen Revenue in Melanoma Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Eristol-Mayers Squibb
11.2.1 Eristol-Mayers Squibb Company Details
11.2.2 Eristol-Mayers Squibb Business Overview
11.2.3 Eristol-Mayers Squibb Melanoma Introduction
11.2.4 Eristol-Mayers Squibb Revenue in Melanoma Business (2016-2021)
11.2.5 Eristol-Mayers Squibb Recent Development
11.3 Eisai
11.3.1 Eisai Company Details
11.3.2 Eisai Business Overview
11.3.3 Eisai Melanoma Introduction
11.3.4 Eisai Revenue in Melanoma Business (2016-2021)
11.3.5 Eisai Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Melanoma Introduction
11.4.4 Roche Revenue in Melanoma Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Genetech
11.5.1 Genetech Company Details
11.5.2 Genetech Business Overview
11.5.3 Genetech Melanoma Introduction
11.5.4 Genetech Revenue in Melanoma Business (2016-2021)
11.5.5 Genetech Recent Development
11.6 Janssen Biotech
11.6.1 Janssen Biotech Company Details
11.6.2 Janssen Biotech Business Overview
11.6.3 Janssen Biotech Melanoma Introduction
11.6.4 Janssen Biotech Revenue in Melanoma Business (2016-2021)
11.6.5 Janssen Biotech Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Melanoma Introduction
11.7.4 Pfizer Revenue in Melanoma Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Melanoma Introduction
11.8.4 Novartis Revenue in Melanoma Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Vical
11.9.1 Vical Company Details
11.9.2 Vical Business Overview
11.9.3 Vical Melanoma Introduction
11.9.4 Vical Revenue in Melanoma Business (2016-2021)
11.9.5 Vical Recent Development
11.10 Ziopharm
11.10.1 Ziopharm Company Details
11.10.2 Ziopharm Business Overview
11.10.3 Ziopharm Melanoma Introduction
11.10.4 Ziopharm Revenue in Melanoma Business (2016-2021)
11.10.5 Ziopharm Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Melanoma Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Radiation Therapy
Table 6. Global Melanoma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Melanoma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Melanoma Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Melanoma Market Share by Regions (2016-2021)
Table 10. Global Melanoma Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Melanoma Market Share by Regions (2022-2027)
Table 12. Melanoma Market Trends
Table 13. Melanoma Market Drivers
Table 14. Melanoma Market Challenges
Table 15. Melanoma Market Restraints
Table 16. Global Melanoma Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Melanoma Market Share by Players (2016-2021)
Table 18. Global Top Melanoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma as of 2020)
Table 19. Ranking of Global Top Melanoma Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Melanoma Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Melanoma Product Solution and Service
Table 23. Date of Enter into Melanoma Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Melanoma Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Melanoma Revenue Market Share by Type (2016-2021)
Table 27. Global Melanoma Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Melanoma Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Melanoma Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Melanoma Revenue Market Share by Application (2016-2021)
Table 31. Global Melanoma Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Melanoma Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Melanoma Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Melanoma Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Melanoma Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Melanoma Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Melanoma Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Melanoma Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Melanoma Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Melanoma Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Melanoma Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Melanoma Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Melanoma Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Melanoma Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Melanoma Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Melanoma Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Melanoma Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Melanoma Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Melanoma Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Melanoma Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Melanoma Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Melanoma Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Melanoma Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Melanoma Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Melanoma Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Melanoma Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Melanoma Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Melanoma Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Melanoma Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Melanoma Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Melanoma Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Melanoma Market Size by Country (2022-2027) & (US$ Million)
Table 63. Amgen Company Details
Table 64. Amgen Business Overview
Table 65. Amgen Melanoma Product
Table 66. Amgen Revenue in Melanoma Business (2016-2021) & (US$ Million)
Table 67. Amgen Recent Development
Table 68. Eristol-Mayers Squibb Company Details
Table 69. Eristol-Mayers Squibb Business Overview
Table 70. Eristol-Mayers Squibb Melanoma Product
Table 71. Eristol-Mayers Squibb Revenue in Melanoma Business (2016-2021) & (US$ Million)
Table 72. Eristol-Mayers Squibb Recent Development
Table 73. Eisai Company Details
Table 74. Eisai Business Overview
Table 75. Eisai Melanoma Product
Table 76. Eisai Revenue in Melanoma Business (2016-2021) & (US$ Million)
Table 77. Eisai Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Melanoma Product
Table 81. Roche Revenue in Melanoma Business (2016-2021) & (US$ Million)
Table 82. Roche Recent Development
Table 83. Genetech Company Details
Table 84. Genetech Business Overview
Table 85. Genetech Melanoma Product
Table 86. Genetech Revenue in Melanoma Business (2016-2021) & (US$ Million)
Table 87. Genetech Recent Development
Table 88. Janssen Biotech Company Details
Table 89. Janssen Biotech Business Overview
Table 90. Janssen Biotech Melanoma Product
Table 91. Janssen Biotech Revenue in Melanoma Business (2016-2021) & (US$ Million)
Table 92. Janssen Biotech Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Melanoma Product
Table 96. Pfizer Revenue in Melanoma Business (2016-2021) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Revenue in Melanoma Business (2016-2021) & (US$ Million)
Table 101. Novartis Recent Development
Table 102. Vical Company Details
Table 103. Vical Business Overview
Table 104. Vical Melanoma Product
Table 105. Vical Revenue in Melanoma Business (2016-2021) & (US$ Million)
Table 106. Vical Recent Development
Table 107. Ziopharm Company Details
Table 108. Ziopharm Business Overview
Table 109. Ziopharm Melanoma Product
Table 110. Ziopharm Revenue in Melanoma Business (2016-2021) & (US$ Million)
Table 111. Ziopharm Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Melanoma Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Immunotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Radiation Therapy Features
Figure 6. Global Melanoma Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Melanoma Report Years Considered
Figure 11. Global Melanoma Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Melanoma Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Melanoma Market Share by Regions: 2020 VS 2027
Figure 14. Global Melanoma Market Share by Regions (2022-2027)
Figure 15. Global Melanoma Market Share by Players in 2020
Figure 16. Global Top Melanoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Melanoma Revenue in 2020
Figure 18. Global Melanoma Revenue Market Share by Type (2016-2021)
Figure 19. Global Melanoma Revenue Market Share by Type (2022-2027)
Figure 20. North America Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Melanoma Market Share by Type (2016-2027)
Figure 22. North America Melanoma Market Share by Application (2016-2027)
Figure 23. North America Melanoma Market Share by Country (2016-2027)
Figure 24. United States Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Melanoma Market Share by Type (2016-2027)
Figure 28. Europe Melanoma Market Share by Application (2016-2027)
Figure 29. Europe Melanoma Market Share by Country (2016-2027)
Figure 30. Germany Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Melanoma Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Melanoma Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Melanoma Market Share by Region (2016-2027)
Figure 40. China Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Melanoma Market Share by Type (2016-2027)
Figure 48. Latin America Melanoma Market Share by Application (2016-2027)
Figure 49. Latin America Melanoma Market Share by Country (2016-2027)
Figure 50. Mexico Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Melanoma Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Melanoma Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Melanoma Market Share by Country (2016-2027)
Figure 56. Turkey Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Melanoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Amgen Revenue Growth Rate in Melanoma Business (2016-2021)
Figure 60. Eristol-Mayers Squibb Revenue Growth Rate in Melanoma Business (2016-2021)
Figure 61. Eisai Revenue Growth Rate in Melanoma Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Melanoma Business (2016-2021)
Figure 63. Genetech Revenue Growth Rate in Melanoma Business (2016-2021)
Figure 64. Janssen Biotech Revenue Growth Rate in Melanoma Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Melanoma Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Melanoma Business (2016-2021)
Figure 67. Vical Revenue Growth Rate in Melanoma Business (2016-2021)
Figure 68. Ziopharm Revenue Growth Rate in Melanoma Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---